Clinical trial
Stellate Ganglion Block for Preserving Arteriovenous Fistula in Hemodialysis Patients Undergoing Major Lower Limb Orthopedic Surgery: A Randomized Controlled Trial
Name
900/2/24
Description
The aim of this study is to evaluate the role of stellate ganglion blockade (SGB) for preserving arteriovenous fistula in hemodialysis patients undergoing major lower limb orthopedic surgery.
Trial arms
Trial start
2024-03-09
Estimated PCD
2024-09-01
Trial end
2024-09-01
Status
Recruiting
Treatment
Stellate ganglion block
Patient will receive preemptive stellate ganglion block (SGB) just before spinal anesthesia.
Arms:
Stellate ganglion blockade
Size
50
Primary endpoint
Fistula flow rate
7th day postoperatively
Eligibility criteria
Inclusion Criteria:
* Age 21 to 75 years.
* Both sexes.
* American Society of Anesthesiologists (ASA) physical status III.
* Chronic renal failure (CRF) patients.
* Undergoing major lower limb orthopedic surgery.
Exclusion Criteria:
* Psychiatric disorders.
* History of substance abuse.
* Ipsilateral brachial and radial artery stenosis.
* Allergy to local anesthetics.
* Cardiovascular and respiratory disorders.
* Coagulopathy.
* Use of vasoactive medications.
* Obesity (body mass index \>30 kg/m2).
* Smoking.
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'NONE'}}, 'enrollmentInfo': {'count': 50, 'type': 'ESTIMATED'}}
Updated at
2024-03-12
1 organization
1 product
4 indications
Organization
Aswan UniversityProduct
Stellate ganglion blockIndication
Stellate Ganglion BlockIndication
Arteriovenous FistulaIndication
Renal Replacement TherapyIndication
Major Lower Limb Orthopedic Surgery